New symptoms and prevalence of postacute COVID-19 syndrome among nonhospitalized COVID-19 survivors.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 10 2022
Historique:
received: 25 01 2022
accepted: 26 09 2022
entrez: 8 10 2022
pubmed: 9 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

The aim of this study was to assess postacute coronavirus disease 2019 (COVID-19) syndrome (PACS) symptoms according to the onset of the infection while evaluating the effect of COVID-19 vaccination on the symptoms of PACS. We conducted a retrospective single-center cohort study in which nonhospitalized COVID-19 survivors and healthy controls were compared for the occurrence of PACS. The total number of patients in this study was 472. At 6-12 and > 12 months after the infection, COVID-19 survivors had a significantly higher incidence of posttraumatic stress disorder (PTSD) and anxiety than the non-COVID-19 cohort. Furthermore, depression, cognitive deficit, tics, impaired quality of life and general health impairment were significantly more prevalent among COVID-19 survivors at < 6 months, 6-12 months and > 12 months than in the non-COVID-19 cohort. However, respiratory symptoms were significantly more prevalent among COVID-19 survivors only in the first 6 months after infection. In addition, cognitive deficit (OR = 0.15; 95% CI 0.03-0.87) and impaired quality of life (B = - 2.11; 95% CI - 4.21 to - 0.20) were significantly less prevalent among vaccinated COVID-19 survivors than among nonvaccinated survivors. Longitudinal studies are needed to establish the time that should elapse after COVID-19 infection for the symptoms of PACS to appear. Randomized clinical trials are needed to assess the possibility that COVID-19 vaccines might relieve PACS symptoms.

Identifiants

pubmed: 36209281
doi: 10.1038/s41598-022-21289-y
pii: 10.1038/s41598-022-21289-y
pmc: PMC9547088
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16921

Informations de copyright

© 2022. The Author(s).

Références

Open Respir Med J. 2013;7:1-5
pubmed: 23494521
Res Sq. 2021 Mar 01;:
pubmed: 33688642
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):
pubmed: 33446511
Lancet Infect Dis. 2022 Jan;22(1):43-55
pubmed: 34480857
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Occup Med (Lond). 2017 Aug 1;67(6):496-497
pubmed: 28898975
Libyan J Med. 2022 Dec;17(1):2010337
pubmed: 34895104
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
Expert Rev Endocrinol Metab. 2021 May;16(3):147-153
pubmed: 33818239
Brain Behav Immun. 2022 Jul;103:154-162
pubmed: 35447302
Lancet. 2021 Aug 28;398(10302):747-758
pubmed: 34454673
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
JAMA Netw Open. 2021 Sep 1;4(9):e2127403
pubmed: 34586367
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychol Bull. 2017 Jun;143(6):636-675
pubmed: 28368148
Clin Microbiol Infect. 2021 Oct;27(10):1507-1513
pubmed: 34111579
ERJ Open Res. 2021 May 24;7(2):
pubmed: 34041295
Arch Dis Child. 2021 Mar 6;:
pubmed: 33677431
Vaccines (Basel). 2021 May 12;9(5):
pubmed: 34066007
BMC Med Res Methodol. 2002 Jun 17;2:8
pubmed: 12069695
Int J Psychiatry Clin Pract. 2021 Oct 28;:1-10
pubmed: 34709105
Geriatr Gerontol Int. 2009 Mar;9(1):54-61
pubmed: 19260980
SAGE Open Med Case Rep. 2021 Aug 14;9:2050313X211039377
pubmed: 34408879
J Med Virol. 2020 Jul;92(7):919-923
pubmed: 32297983
BMC Psychiatry. 2019 Sep 18;19(1):291
pubmed: 31533674
PLoS One. 2020 Sep 17;15(9):e0238678
pubmed: 32941467
Infect Dis (Lond). 2021 Oct;53(10):737-754
pubmed: 34024217
J Behav Med. 2021 Dec;44(6):741-759
pubmed: 34128179
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7847-7857
pubmed: 34982447
Crit Care. 2019 Aug 7;23(1):276
pubmed: 31391069
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
Annu Rev Immunol. 2020 Apr 26;38:597-620
pubmed: 32340575
Am J Med. 2021 Apr;134(4):462-467.e1
pubmed: 33444589

Auteurs

Asma S Albtoosh (AS)

Department of Respiratory and Sleep Medicine, Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Ahmad A Toubasi (AA)

Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan. tubasi_ahmad@yahoo.com.

Khaled Al Oweidat (K)

Department of Respiratory and Sleep Medicine, Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Manar M Hasuneh (MM)

Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan.

Abdullah H Alshurafa (AH)

Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan.

Daniah L Alfaqheri (DL)

Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan.

Randa I Farah (RI)

Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH